Skip to main content
NewslettersWatchlist

Viking Thera(VKTX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low65.50
Day High68.48
Open:66.26
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
3 Magnificent Stocks That Could Double or More by 2030
Motley Fool
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
Motley Fool
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
Barchart
This Small-Cap Biotech Could Gain Over 165%, Says Wall Street
Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
Motley Fool
Is it Too Late to Buy Viking Therapeutics Stock?
Motley Fool
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
Motley Fool
Viking Therapeutics Just Announced More Positive Results: Time to Buy?
Motley Fool
1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now
Motley Fool
2 Potentially Explosive Stocks to Buy in April
Motley Fool
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
Motley Fool
Could Viking Therapeutics Stock Be a Millionaire Maker?
Motley Fool
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
Motley Fool
Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
Motley Fool
5 Top Stocks to Buy in April
Motley Fool
Is It Too Late to Buy Viking Therapeutics Stock?
Motley Fool
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
Motley Fool
Why Viking Therapeutics Stock Was Rocketing Higher This Week
Motley Fool
5 Things You Need to Know If You Buy Viking Therapeutics Stock Today
Barchart
Stocks Give Up Early Gains as Nvidia Weighs on Chip Stocks
Barchart
Stocks Push Higher on Economic Optimism
Motley Fool
Why Viking Therapeutics Stock Is Skyrocketing Today
Barchart
Stocks Climb on Positive Corporate News
Motley Fool
Viking Therapeutics: Buy, Sell, or Hold?
Motley Fool
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
Motley Fool
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
Barchart
3 'Strong Buy' Growth Stocks to Scoop Up Now
Motley Fool
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
Motley Fool
Is Viking Therapeutics Stock a Millionaire Maker?
Motley Fool
Where Will Viking Therapeutics Stock Be in 10 Years?
Motley Fool
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
Motley Fool
Could Viking Therapeutics Become the Next Eli Lilly?

Profile

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.